Sunday, August 07, 2016 5:25:35 AM
What amazes me ... is for the suppose number of people that attended that meeting we really got very very little information back and that is disappointing. I mean ... come on man .... Plexus was named, Cadence was confirmed, the end effectors doesn't want to be named, but most of all the world leading liver surgeon wants this robot because it can do what no other platform can do atm. Talk of Verb and Ethicon went on for months, including myself when in fact we knew from the meeting that was not the case.
Anyway .... this board has become a meeting place for silly gossip and a place to cry, which ... I suppose has a purpose. In any case, I no longer feel bad about buying back in at 1.36 other than if I had done it now I'd have a lot more shares. Point is, this this is going to make it one way or another, of that I have no doubts. The only time I would be concerned was if something happened to Dr. Fowler. In my opinion he is the cheif cook and bottle washer of the entire organization and he's the one checking vital signs along the way. It's been painfully slow but they are taking the proper steps to get this done, and done with excellence. FDA no longer concerns me with this man at the helm. All T's will be crossed and all I's will be dotted. Guaranteed.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM